Patent details
EP3043797 Title: TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
Basic Information
- Publication number:
- EP3043797
- PCT Application Number:
- US2014054757
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP148420425
- PCT Publication Number:
- WO2015035376
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
- French Title of Invention:
- TRAITEMENT D'INFECTIONS AU MOYEN DE CEFTOLOZANE/TAZOBACTAM CHEZ DES SUJETS AYANT UNE FONCTION RÉNALE ALTÉRÉE
- German Title of Invention:
- BEHANDLUNG VON INFEKTIONEN MIT CEFTOLOZAN/TAZOBACTAM BEI PERSONEN MIT BEEINTRÄCHTIGTER NIERENFUNKTION
- SPC Number:
Dates
- Filing date:
- 09/09/2014
- Grant date:
- 08/04/2020
- EP Publication Date:
- 20/07/2016
- PCT Publication Date:
- 12/03/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/04/2020
- EP B1 Publication Date:
- 08/04/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/09/2020
- Expiration date:
- 09/09/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/09/2022
- Name:
- Merck Sharp & Dohme LLC
- Address:
- 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States (US)
History of Owners
- From:
- 01/04/2020
- To:
- 16/09/2022
- Name:
- Merck Sharp & Dohme Corp.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065, United States (US)
Inventor
1
- Name:
- HERSHBERGER, Elham
- Address:
- United States (US)
2
- Name:
- CHANDORKAR, Gurudatt
- Address:
- United States (US)
3
- Name:
- MILLER, Benjamin
- Address:
- United States (US)
4
- Name:
- XIAO, Alan
- Address:
- United States (US)
5
- Name:
- KRISHNA, Gopal
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201361875358 P
- Priority Date:
- 09/09/2013
- Priority Country:
- United States (US)
2
- Priority Number:
- 201361883579 P
- Priority Date:
- 27/09/2013
- Priority Country:
- United States (US)
3
- Priority Number:
- 201461984299 P
- Priority Date:
- 25/04/2014
- Priority Country:
- United States (US)
4
- Priority Number:
- 201461988085 P
- Priority Date:
- 02/05/2014
- Priority Country:
- United States (US)
5
- Priority Number:
- 201462002457 P
- Priority Date:
- 23/05/2014
- Priority Country:
- United States (US)
6
- Priority Number:
- 201462046417 P
- Priority Date:
- 05/09/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/19; A61K 31/431; A61K 31/546; A61P 31/00; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202015
- Publication date:
- 08/04/2020
- Description:
- Grant (B1)
2
- Issue number:
- 202104
- Publication date:
- 27/01/2021
- Description:
- Opposition procedure started
3
- Issue number:
- 202242
- Publication date:
- 19/10/2022
- Description:
- Transfer of Rights
4
- Issue number:
- 202252
- Publication date:
- 28/12/2022
- Description:
- Opposition rejected; Patent maintained as granted
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|